Pascal Detampel
Impact in
- Pharmaceutical Science top 5%
- Geriatrics and Gerontology top 5%
Papers in
-
- Immunotherapy and Immune Responses 3
-
- RNA Interference and Gene Delivery 8
- Advanced biosensing and bioanalysis techniques 6
- Extracellular vesicles in disease 4
- Protein purification and stability 3
- Co-authors
- Jörg Huwyler (25 shared papers)Ali Dehshahri (2 shared papers)Susanne Schenk (3 shared papers)Elahehnaz Parhizkar (1 shared paper)Dominik Witzigmann (4 shared papers)Mareike Beck (1 shared paper)Stephan Krähenbühl (1 shared paper)Anutosh Ganguly (6 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Scientific Reports (3 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)European Journal of Pharmaceutical Sciences (2 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- SwitzerlandCanadaUnited States
In The Last Decade
Pascal Detampel
36 papers receiving 1.3k citations
Pascal Detampel's Hit Papers
Peers
Comparison fields: 5 of 113
- Pharmaceutical Science 109
- Geriatrics and Gerontology 58
- Biomaterials 194
- Immunology 280
- Molecular Biology 638
Countries citing papers authored by Pascal Detampel
This map shows the geographic impact of Pascal Detampel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Detampel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Detampel more than expected).
Fields of papers citing papers by Pascal Detampel
This network shows the impact of papers produced by Pascal Detampel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Detampel. The network helps show where Pascal Detampel may publish in the future.
Co-authors
The 25 scholars most cited alongside Pascal Detampel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Polyethylenimine (PEI) in gene therapy: Current status and clinical applications Hit paper breakdown → | 2023 | 221 |
| 2 | 2017 | 134 | |
| 3 | 2012 | 121 | |
| 4 | 2014 | 94 | |
| 5 | 2017 | 89 | |
| 6 | 2020 | 68 | |
| 7 | 2020 | 58 | |
| 8 | 2017 | 58 | |
| 9 | 2018 | 56 | |
| 10 | 2019 | 47 | |
| 11 | 2017 | 41 | |
| 12 | 2022 | 34 | |
| 13 | 2019 | 31 | |
| 14 | 2013 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2018 | 23 | |
| 17 | 2019 | 21 | |
| 18 | 2022 | 19 | |
| 19 | 2023 | 18 | |
| 20 | 2014 | 18 |
About Pascal Detampel
Pascal Detampel is a scholar working on Immunology, Molecular Biology, Pharmaceutical Science, Biomaterials and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Advanced biosensing and bioanalysis techniques (6 papers), Nanoparticle-Based Drug Delivery (4 papers), Extracellular vesicles in disease (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Protein purification and stability (3 papers), Immunotherapy and Immune Responses (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Pharmaceutical Science (109 citations), Geriatrics and Gerontology (58 citations), Biomaterials (194 citations), Immunology (280 citations) and Molecular Biology (638 citations). Pascal Detampel has collaborated with scholars based in Switzerland, Canada and United States. Frequent co-authors include Jörg Huwyler, Ali Dehshahri, Susanne Schenk, Elahehnaz Parhizkar, Dominik Witzigmann, Mareike Beck, Stephan Krähenbühl, Anutosh Ganguly, Sandro Sieber and Philip Grossen. Their work appears in journals such as Journal of Controlled Release, Scientific Reports, European Journal of Pharmaceutics and Biopharmaceutics, European Journal of Pharmaceutical Sciences and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.